When it comes to the polarizing penny stock space, the author of today’s article acknowledges that the dilemma is the following: “How are investors supposed to separate the penny stocks […]
read more
Seeking Abnormal Returns In “The New Abnormal”
As uncertain as things are right now, the author of today’s article advises that there are several categories of companies that will move higher in the current stock market: companies […]
read more
For The Best In Biotech, Look To The Baker Brothers
Given the volatility associated with the industry, when picking biotech stocks it may make sense to look to the best for ideas – and when it comes to the biotech […]
read more
The Reasons (Including One “Hidden Factor”) Why This Biopharmaceutical Stock Has Nearly Doubled Since Mid-March
Shares of the commercial-stage biopharmaceutical company highlighted in today’s article have nearly doubled since mid-March. The biggest reason why? The debut of the company’s hot new migraine drug, which it […]
read more
How To “Turbocharge” A Position In Volatile Silver
When it comes to precious metals, the author of today’s article declares “I favor gold as a long-term investment, but when it comes to trading, silver is my sardine of […]
read more
4 Biotech Stocks Worthy Of Close Attention
When it comes to biotech’s performance over the last several weeks, the author of today’s article notes that “Part of the sector’s rise is undoubtedly attributed to the work toward […]
read more
Charting Biotech’s Next Moves
The niche market segment that’s been dominating the attention of active traders over the last several weeks? Biotechnology! So where is biotech likely headed from here? Today’s article looks to […]
read moreThis Options Trade Could Net A Quick 300% Gain By Taking Advantage Of Financials’ Weakness
Today’s article outlines an options trade that could net a quick 300% gain by taking advantage of one of the weakest sectors in the market today (even before COVID-19 hit): […]
read moreWill The Coronavirus Be Different For This Perennial Disease Outbreak Loser?
As has been the case with many small-cap biotech stocks amid the coronavirus pandemic, traders have gotten excited in recent weeks about the stock examined in today’s article, one which, […]
read moreThese 25 Struggling Small-Company Stocks Could Surge, Especially If Buyers Swoop In
Some of the best opportunities going forward may be among the worst-performing small-company stocks that have gone public over the last 11 years, advises the chief equity strategist at BTIG. […]
read more